Pharmacovigilance

Veterinary pharmacovigilance monitors the safety of veterinary medicines, including vaccines, used for the prophylaxis, diagnosis or treatment of disease in animals once they reach the market after authorization. The task of veterinary pharmacovigilance is to ensure:

• Safety of use of veterinary medicines in animals
• Safety of animal-derived food
• Safety for people who come into contact with veterinary medicines
• Safety for the environment

This can only be achieved if all observed adverse events, either by veterinarian, animal keeper or pet owner, are reported to the national competent authorities or to the marketing authorization holder of the veterinary medicine. The following observations are considered to be adverse events:

• Undesired effects in animals (side-effects), either known or unknown
• Lack of expected efficacy (treatment failure)
• Off-label use (side effects after use in other than authorized dosages, animal species or route of administration, or in an unauthorized combination with other medicines)
• Human reactions after exposure to a veterinary medicine
• Potential environmental problems
• Validity of established withdrawal periods (residue issues)

All adverse events can be reported to your national competent authority or to Huvepharma using the following email addresses; for adverse events in the EU please email [email protected], and for the rest of the world please email [email protected].